• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.在实验性肺动脉高压中,非高碳酸血症酸中毒时肺血管反应性改善和肥厚重构减少。
Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L875-90. doi: 10.1152/ajplung.00293.2011. Epub 2012 Jan 27.
2
Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.低氧和野百合碱诱导肺动脉高压大鼠肺动脉血管收缩功能障碍及一氧化氮介导的舒张功能障碍。
J Pharmacol Exp Ther. 2010 Feb;332(2):455-62. doi: 10.1124/jpet.109.160119. Epub 2009 Nov 13.
3
Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension.碳酸酐酶抑制可改善肺动脉高压的苏金-低氧模型中的肺动脉反应性和一氧化氮介导的舒张功能。
Am J Physiol Regul Integr Comp Physiol. 2021 Jun 1;320(6):R835-R850. doi: 10.1152/ajpregu.00362.2020. Epub 2021 Apr 7.
4
Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.肺动脉血管收缩功能受损和一氧化氮介导的舒张功能障碍导致 Sugen 缺氧大鼠模型中的严重肺动脉高压。
J Pharmacol Exp Ther. 2018 Feb;364(2):258-274. doi: 10.1124/jpet.117.244798. Epub 2017 Dec 6.
5
Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.长期吸入一氧化氮可减轻大鼠低氧性肺血管重塑,但不能减轻野百合碱诱导的肺血管重塑。
Anesth Analg. 1998 Jan;86(1):74-81. doi: 10.1097/00000539-199801000-00015.
6
A novel Ca2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension.一种新型的 Ca2+ 通道拮抗剂可逆转实验性肺动脉高压中的心肌肥厚和肺小动脉重构。
Eur J Pharmacol. 2013 Feb 28;702(1-3):316-22. doi: 10.1016/j.ejphar.2013.01.050. Epub 2013 Feb 8.
7
Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension.缝隙连接在两种肺动脉高压大鼠模型激动剂引起的收缩反应中的作用。
Respir Res. 2011 Mar 17;12(1):30. doi: 10.1186/1465-9921-12-30.
8
Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.没食子酸水提取物对实验性肺动脉高压的有益作用。
J Ethnopharmacol. 2017 Feb 2;197:184-194. doi: 10.1016/j.jep.2016.07.029. Epub 2016 Jul 9.
9
[Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].[血管紧张素 -(1 - 7)改善野百合碱诱导的大鼠肺动脉高压的内皮依赖性血管舒张功能]
Sheng Li Xue Bao. 2023 Aug 25;75(4):497-502.
10
Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.白藜芦醇逆转野百合碱诱导的肺血管和心脏功能障碍:一种肌球蛋白中 atrogin-1 的潜在作用。
Vascul Pharmacol. 2012 Jan-Feb;56(1-2):64-73. doi: 10.1016/j.vph.2011.11.002. Epub 2011 Nov 25.

引用本文的文献

1
Stress Granule Assembly in Pulmonary Arterial Hypertension.肺动脉高压中的应激颗粒组装。
Cells. 2024 Oct 30;13(21):1796. doi: 10.3390/cells13211796.
2
Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.苏根/低氧诱导的大鼠肺动脉高压的生物学和药理学的最新概述。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):241-283. doi: 10.1089/jamp.2024.0016.
3
Hypoxia enhances interactions between Na/H exchanger isoform 1 and actin filaments ezrin in pulmonary vascular smooth muscle.缺氧增强肺血管平滑肌中钠/氢交换体1亚型与肌动蛋白丝埃兹蛋白之间的相互作用。
Front Physiol. 2023 Feb 28;14:1108304. doi: 10.3389/fphys.2023.1108304. eCollection 2023.
4
Skeletal Muscle Dysfunction in Experimental Pulmonary Hypertension.实验性肺动脉高压中的骨骼肌功能障碍。
Int J Mol Sci. 2022 Sep 18;23(18):10912. doi: 10.3390/ijms231810912.
5
Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.肺动脉高压肺血管功能障碍的机制及其对新型治疗方法的影响。
Am J Physiol Heart Circ Physiol. 2022 May 1;322(5):H702-H724. doi: 10.1152/ajpheart.00021.2022. Epub 2022 Feb 25.
6
Acute Hemodynamic Effect of Acetazolamide in Patients With Pulmonary Hypertension Whilst Breathing Normoxic and Hypoxic Gas: A Randomized Cross-Over Trial.乙酰唑胺对肺动脉高压患者在吸入常氧和低氧气体时的急性血流动力学影响:一项随机交叉试验。
Front Med (Lausanne). 2021 Jul 22;8:681473. doi: 10.3389/fmed.2021.681473. eCollection 2021.
7
Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.乙酰唑胺改善实验性肺动脉高压中的右心室功能和代谢基因失调。
Front Cardiovasc Med. 2021 Jun 17;8:662870. doi: 10.3389/fcvm.2021.662870. eCollection 2021.
8
Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension.碳酸酐酶抑制可改善肺动脉高压的苏金-低氧模型中的肺动脉反应性和一氧化氮介导的舒张功能。
Am J Physiol Regul Integr Comp Physiol. 2021 Jun 1;320(6):R835-R850. doi: 10.1152/ajpregu.00362.2020. Epub 2021 Apr 7.
9
Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.人及实验性肺动脉高压中的脂肪因子和代谢调节剂。
Int J Mol Sci. 2021 Feb 1;22(3):1435. doi: 10.3390/ijms22031435.
10
Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.大麻二酚可改善野百合碱诱导的大鼠肺动脉高压。
Int J Mol Sci. 2020 Sep 25;21(19):7077. doi: 10.3390/ijms21197077.

本文引用的文献

1
A novel murine model of severe pulmonary arterial hypertension.一种新型严重肺动脉高压的小鼠模型。
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1171-82. doi: 10.1164/rccm.201103-0412OC. Epub 2011 Aug 25.
2
Heme oxygenase-1 does not mediate the effects of extracellular acidosis on vascular smooth muscle cell proliferation, migration, and susceptibility to apoptosis.血红素加氧酶-1不介导细胞外酸中毒对血管平滑肌细胞增殖、迁移及凋亡易感性的影响。
J Vasc Res. 2011;48(4):285-96. doi: 10.1159/000321555. Epub 2011 Jan 26.
3
Induction of metabolic acidosis with ammonium chloride (NH4Cl) in mice and rats--species differences and technical considerations.氯化铵(NH₄Cl)诱导小鼠和大鼠代谢性酸中毒——种属差异及技术考量
Cell Physiol Biochem. 2010;26(6):1059-72. doi: 10.1159/000323984. Epub 2011 Jan 4.
4
Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.Rho 激酶抑制剂的抢救治疗可使慢性肺动脉高压幼鼠的右心功能正常化并逆转重构。
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1854-64. doi: 10.1152/ajpheart.00595.2010. Epub 2010 Oct 1.
5
Sex hormones and vascular protection in pulmonary arterial hypertension.性激素与肺动脉高压中的血管保护作用
J Cardiovasc Pharmacol. 2010 Nov;56(5):471-4. doi: 10.1097/FJC.0b013e3181fa8e20.
6
Key role of the RhoA/Rho kinase system in pulmonary hypertension.RhoA/Rho 激酶系统在肺动脉高压中的关键作用。
Pulm Pharmacol Ther. 2011 Feb;24(1):1-14. doi: 10.1016/j.pupt.2010.09.001. Epub 2010 Sep 15.
7
Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.实验性重度肺动脉高压中丛状病变的形成。
Circulation. 2010 Jun 29;121(25):2747-54. doi: 10.1161/CIRCULATIONAHA.109.927681. Epub 2010 Jun 14.
8
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.吸入性曲前列尼尔联合口服药物治疗肺动脉高压的随机对照临床试验。
J Am Coll Cardiol. 2010 May 4;55(18):1915-22. doi: 10.1016/j.jacc.2010.01.027.
9
Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.低氧和野百合碱诱导肺动脉高压大鼠肺动脉血管收缩功能障碍及一氧化氮介导的舒张功能障碍。
J Pharmacol Exp Ther. 2010 Feb;332(2):455-62. doi: 10.1124/jpet.109.160119. Epub 2009 Nov 13.
10
Notch3 signaling promotes the development of pulmonary arterial hypertension.Notch3信号通路促进肺动脉高压的发展。
Nat Med. 2009 Nov;15(11):1289-97. doi: 10.1038/nm.2021. Epub 2009 Oct 25.

在实验性肺动脉高压中,非高碳酸血症酸中毒时肺血管反应性改善和肥厚重构减少。

Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.

机构信息

Harvard Medical School, Brigham and Women's Hospital, Division of Vascular Surgery, Boston, MA 02115, USA.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L875-90. doi: 10.1152/ajplung.00293.2011. Epub 2012 Jan 27.

DOI:10.1152/ajplung.00293.2011
PMID:22287610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3362160/
Abstract

Pulmonary hypertension (PH) is characterized by pulmonary arteriolar remodeling with excessive pulmonary vascular smooth muscle cell (VSMC) proliferation. This results in decreased responsiveness of pulmonary circulation to vasodilator therapies. We have shown that extracellular acidosis inhibits VSMC proliferation and migration in vitro. Here we tested whether induction of nonhypercapnic acidosis in vivo ameliorates PH and the underlying pulmonary vascular remodeling and dysfunction. Adult male Sprague-Dawley rats were exposed to hypoxia (8.5% O(2)) for 2 wk, or injected subcutaneously with monocrotaline (MCT, 60 mg/kg) to develop PH. Acidosis was induced with NH(4)Cl (1.5%) in the drinking water 5 days prior to and during the 2 wk of hypoxic exposure (prevention protocol), or after MCT injection from day 21 to 28 (reversal protocol). Right ventricular systolic pressure (RVSP) and Fulton's index were measured, and pulmonary arteriolar remodeling was analyzed. Pulmonary and mesenteric artery contraction to phenylephrine (Phe) and high KCl, and relaxation to acetylcholine (ACh) and sodium nitroprusside (SNP) were examined ex vivo. Hypoxic and MCT-treated rats demonstrated increased RVSP, Fulton's index, and pulmonary arteriolar thickening. In pulmonary arteries of hypoxic and MCT rats there was reduced contraction to Phe and KCl and reduced vasodilation to ACh and SNP. Acidosis prevented hypoxia-induced PH, reversed MCT-induced PH, and resulted in reduction in all indexes of PH including RVSP, Fulton's index, and pulmonary arteriolar remodeling. Pulmonary artery contraction to Phe and KCl was preserved or improved, and relaxation to ACh and SNP was enhanced in NH(4)Cl-treated PH animals. Acidosis alone did not affect the hemodynamics or pulmonary vascular function. Phe and KCl contraction and ACh and SNP relaxation were not different in mesenteric arteries of all groups. Thus nonhypercapnic acidosis ameliorates experimental PH, attenuates pulmonary arteriolar thickening, and enhances pulmonary vascular responsiveness to vasoconstrictor and vasodilator stimuli. Together with our finding that acidosis decreases VSMC proliferation, the results are consistent with the possibility that nonhypercapnic acidosis promotes differentiation of pulmonary VSMCs to a more contractile phenotype, which may enhance the effectiveness of vasodilator therapies in PH.

摘要

肺动脉高压(PH)的特征是肺小动脉重构,伴有肺血管平滑肌细胞(VSMC)过度增殖。这导致肺循环对血管扩张剂治疗的反应性降低。我们已经表明,细胞外酸中毒可抑制体外 VSMC 的增殖和迁移。在这里,我们测试了体内非高碳酸酸中毒的诱导是否可以改善 PH 及其潜在的肺血管重构和功能障碍。成年雄性 Sprague-Dawley 大鼠暴露于低氧(8.5% O2)2 周,或皮下注射马兜铃酸(MCT,60mg/kg)以发展 PH。在低氧暴露的 2 周前和期间,用 NH4Cl(1.5%)在饮用水中诱导酸中毒(预防方案),或在 MCT 注射后第 21 天至第 28 天(逆转方案)。测量右心室收缩压(RVSP)和富尔顿指数,并分析肺小动脉重构。离体检测肺和肠系膜动脉对苯肾上腺素(Phe)和高 KCl 的收缩以及对乙酰胆碱(ACh)和硝普钠(SNP)的舒张。低氧和 MCT 处理的大鼠表现出 RVSP、富尔顿指数和肺小动脉增厚增加。在低氧和 MCT 大鼠的肺动脉中,对 Phe 和 KCl 的收缩减少,对 ACh 和 SNP 的血管舒张减少。酸中毒可预防低氧诱导的 PH,逆转 MCT 诱导的 PH,并降低包括 RVSP、富尔顿指数和肺小动脉重构在内的所有 PH 指标。Phe 和 KCl 收缩以及 ACh 和 SNP 舒张在 NH4Cl 处理的 PH 动物中得到保留或改善。单独的酸中毒不会影响血液动力学或肺血管功能。各组肠系膜动脉的 Phe 和 KCl 收缩以及 ACh 和 SNP 舒张均无差异。因此,非高碳酸酸中毒可改善实验性 PH,减轻肺小动脉增厚,并增强肺血管对血管收缩剂和血管扩张剂刺激的反应性。结合我们发现酸中毒可减少 VSMC 增殖的结果,表明非高碳酸酸中毒可促进肺 VSMC 向更收缩表型分化,这可能增强 PH 中血管扩张剂治疗的效果。